(SCL) Stepan - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8585861003
SCL: Surfactants, Polymers, Specialty, Chemicals, Detergents, Emulsifiers
Stepan Company, a specialty chemicals manufacturer with a rich history dating back to 1932, operates through three distinct segments: Surfactants, Polymers, and Specialty Products. Each segment is tailored to serve specific industries, making Stepan a pivotal player in the specialty chemicals sector.
The Surfactants segment is the cornerstone of Stepans business, producing surfactants that are integral to consumer and industrial cleaning products. These include detergents for laundry and dishwashing, as well as shampoos and body washes. Beyond personal care, these surfactants find applications in industrial settings, such as in fabric softeners and disinfectants. Their versatility extends to agricultural emulsifiers and industrial latex systems, showcasing their broad utility.
The Polymers segment focuses on polyurethane polyols, essential for manufacturing rigid foam insulation used in construction. This segment also produces polyester resins and phthalic anhydride, which are crucial for coatings, adhesives, and plastics in construction and automotive industries. These products are fundamental to modern manufacturing, contributing to energy efficiency and material durability.
The Specialty Products segment caters to the food, flavoring, and pharmaceutical industries, offering flavors, emulsifiers, and solubilizers. These ingredients enhance product appeal and performance, making them indispensable in nutritional supplements and pharmaceuticals.
Stepans financials highlight its stability and growth potential, with a market cap of $1.4 billion. The trailing P/E of 31.17 and forward P/E of 16.75 suggest investor confidence in its future prospects. A P/B ratio of 1.15 indicates the companys assets are well-valued, while a P/S of 0.64 reflects efficient revenue generation relative to its market value.
Headquartered in Northbrook, Illinois, Stepans commitment to innovation and sustainability positions it as a leader in specialty chemicals. Its diverse product portfolio and strategic market presence make it an attractive consideration for investors seeking exposure to this sector.
Additional Sources for SCL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SCL Stock Overview
Market Cap in USD | 1,294m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 1992-03-17 |
SCL Stock Ratings
Growth 5y | -72.2% |
Fundamental | -4.26% |
Dividend | 61.3% |
Rel. Strength | -35.3 |
Analysts | 3.5/5 |
Fair Price Momentum | 36.85 USD |
Fair Price DCF | 128.93 USD |
SCL Dividends
Dividend Yield 12m | 2.54% |
Yield on Cost 5y | 1.74% |
Annual Growth 5y | 5.97% |
Payout Consistency | 100.0% |
SCL Growth Ratios
Growth Correlation 3m | -83.7% |
Growth Correlation 12m | -89% |
Growth Correlation 5y | -76.4% |
CAGR 5y | -12.29% |
CAGR/Max DD 5y | -0.19 |
Sharpe Ratio 12m | -1.14 |
Alpha | -46.14 |
Beta | 0.819 |
Volatility | 29.41% |
Current Volume | 136.5k |
Average Volume 20d | 123.6k |
As of April 09, 2025, the stock is trading at USD 45.26 with a total of 136,525 shares traded.
Over the past week, the price has changed by -16.48%, over one month by -21.87%, over three months by -26.45% and over the past year by -47.24%.
Neither. Based on ValueRay Fundamental Analyses, Stepan is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -4.26 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SCL as of April 2025 is 36.85. This means that SCL is currently overvalued and has a potential downside of -18.58%.
Stepan has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold SCL.
- Strong Buy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, SCL Stepan will be worth about 39.9 in April 2026. The stock is currently trading at 45.26. This means that the stock has a potential downside of -11.82%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 85 | 87.8% |
Analysts Target Price | 97 | 114.3% |
ValueRay Target Price | 39.9 | -11.8% |